Getinge Group: Getinge Strengthens Competitiveness Through Concentration of Production Units and Establishes Global Innovation Center

Regulatory News:

Getinge (STO:GETIB) continues to enhance its operational efficiency by further concentrating its production to fewer units with greater resources. As a step in this pursuit, the Extended Care business area intends to relocate the manufacturing of its bath and hygiene products from Eslöv, Sweden, to the production facility in Poznan, Poland, and to a third party.

The planned change will lead to the successive discontinuation of production in Eslöv. All staff in Arjo Hospital Equipment in Eslöv and at Meditechnik in Germany will be affected. About 150 employees in Eslöv and at Meditechnik are expected to be made redundant, the majority in Sweden. The staff in Eslöv and at Meditechnik was informed of the planned changes this morning.

"We will initiate discussions with the Swedish Public Employment Service and the municipality to support the process of finding new employment for the staff who are expected to be made redundant due to the planned discontinuation of the operation in Eslöv,” says Alex Myers, Executive Vice President of Extended Care.

The discontinuation is scheduled to commence in mid-2013 and is expected to be completed during the second half of 2014.

Getinge’s Extended Care business area, which operates under the ArjoHuntleigh brand, will at the same time continue its intense focus on research and development and on establishing a global innovation center in Malmö. The center will concentrate on developing the company’s global range of mobility and hygiene products, and will employ about 65 individuals. The center is expected to open in spring 2013.

GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency in healthcare, care and research. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control in healthcare and contamination prevention in biotechnology. MAQUET specializes in solutions, therapies and products for surgical interventions and intensive care.

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.

This information was brought to you by Cision http://news.cision.com